Product Information
ROXYBOND 15 MG TABLET is a brand product labeled by Protega Pharmaceuticals Inc, priced at $18.1912 per EA under NDC 81140010210. Its NADAC has been published 52 times since Mar 19, 2025.
FDA first approved this application on Apr 20, 2017.
The High Outlier badge above means this manufacturer's average price in the Oxycodone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Protega Pharmaceuticals IncNDC
81140010210
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
OXYCODONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209777FDA Approved
4/20/2017
On Market Since
4/20/2017
Pharmacological Classes
Price Statistics
The NADAC for ROXYBOND 15 MG TABLET has been published 52 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.1912 per EA |
|---|---|
| All-time high | $18.1912 (Mar 11, 2026) |
| All-time low | $18.1912 (Mar 19, 2025) |
| 52-week high | $18.1912 |
| 52-week low | $18.1912 |
| Median price | $18.1912 |
| Average price | $18.1912 |
| Largest weekly change | 0.0% (Mar 26, 2025) |
| Weeks tracked | 52 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROXYBOND 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROXYBOND 15 MG TABLET, manufactured by Protega Pharmaceuticals Inc, is $18.1912 per EA (NDC 81140010210), effective Mar 11, 2026.
How has the price of ROXYBOND 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROXYBOND 15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for ROXYBOND 15 MG TABLET?
Since Mar 19, 2025, the NADAC for ROXYBOND 15 MG TABLET has ranged from a low of $18.1912 (Mar 19, 2025) to a high of $18.1912 (Mar 11, 2026), with a median of $18.1912 per EA.
Are there cheaper alternatives to ROXYBOND 15 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE HCL (IR) 15 MG TAB, is $0.1974 per EA — about 99% below ROXYBOND 15 MG TABLET.
Who manufactures ROXYBOND 15 MG TABLET?
ROXYBOND 15 MG TABLET (NDC 81140010210) is labeled by Protega Pharmaceuticals Inc, and CMS classifies it as a brand product.